MARKET

VAXX

VAXX

VAXXINITY INC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.97
-1.13
-15.92%
After Hours: 6.16 +0.19 +3.18% 17:51 01/27 EST
OPEN
7.27
PREV CLOSE
7.10
HIGH
7.27
LOW
5.87
VOLUME
286.34K
TURNOVER
--
52 WEEK HIGH
22.77
52 WEEK LOW
5.11
MARKET CAP
744.78M
P/E (TTM)
-8.4849
1D
5D
1M
3M
1Y
5Y
Sierra Oncology, Aptorum top healthcare gainers; Inhibrx, HTG Molecular among losers
Gainers: Sierra Oncology (NASDAQ:SRRA) +46%. Aptorum Group (NASDAQ:APM) +36%. Checkpoint Therapeutics (NASDAQ:CKPT) +13%. Allscripts Healthcare Solutions (NASDAQ:MDRX) +11%. Amarin (NASDAQ:AMRN) +8%. Losers: Inhibrx (NASDAQ:INBX) -18%. HTG Molecular Diagno...
Seekingalpha · 2d ago
20 Stocks Moving in Tuesday's Pre-Market Session
Gainers
Benzinga · 2d ago
Volatility in Vaxxinity continues; shares down 7% today
Trading in Vaxxinity (VAXX -7.1%) has been very volatile over the last week, and today, shares are right around where there were when the stock opened a week ago. On
Seekingalpha · 01/20 18:22
38 Stocks Moving In Thursday's Mid-Day Session
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 29.8% to $0.2550. Baudax Bio, last month, announced a $4.2 million registered direct offering.
Benzinga · 01/20 17:00
Vaxxinity Shares Drop in Thursday Trading Following Wednesday Spike
MT Newswires · 01/20 14:34
CLFD, NURO and PIXY among mid-day movers
Gainers: Zogenix (NASDAQ:ZGNX) +67%. Vivos Therapeutics (NASDAQ:VVOS) +48%. G Medical Innovations (NASDAQ:GMVD) +46%. ShiftPixy (NASDAQ:PIXY) +31%. Splash Beverage (NYSE:SBEV) +28%. New Pacific (NYSE:NEWP) +18%. Gamida Cell (NASDAQ:GMDA) +18%. Vaxxinity (N...
Seekingalpha · 01/19 17:38
35 Stocks Moving In Wednesday's Mid-Day Session
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion.
Benzinga · 01/19 17:00
Vaxxinity up 18% on 10x higher than normal volume
Shares of Vaxxinity (VAXX +17.8%) are on a tear this morning, with volume up  10 times the normal average. The daily average volume for the stock is 431,693. As of
Seekingalpha · 01/19 16:34
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VAXX. Analyze the recent business situations of VAXXINITY INC through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.70%
Pharmaceuticals & Medical Research
+0.35%
Key Executives
Director
Gregory R. Blatt
Chief Medical Officer
Ulo Palm
Chief Scientific Officer
Farshad Guirakhoo
General Counsel and Secretary
René Paula Molina
Co-Founder and Executive Chairman of the Board
Louis Reese
Interim Chief Financial Officer, Treasurer and Principal Accounting Officer
Martin Doran
Director
James Chui
Co-Founder, President, Chief Executive Officer and Director
Mei Mei Hu
Director
Peter Diamandis
No Data
About VAXX
Vaxxinity, Inc. is a biotechnology company. The Company’s synthetic peptide vaccine platform (Vaxxine Platform) enables a new class of therapeutics that will improve the access to treatments for a range of indications. Its Vaxxine Platform is designed to connect the immune system to convert the body into its own drug factory, stimulating the production of antibodies with a therapeutic or protective effect. Its technology uses synthetic peptides to mimic and optimally combine biological epitopes in order to selectively activate the immune system, producing antibodies against only the desired targets, including self-antigens, making possible the safe and effective treatment of chronic diseases by vaccines. The modular and synthetic nature of its Vaxxine Platform provides significant in candidate development and has generated multiple product candidates that it is designing for many chronic diseases.

Webull offers kinds of Vaxxinity Inc stock information, including NASDAQ:VAXX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VAXX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VAXX stock methods without spending real money on the virtual paper trading platform.